BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 20696663)

  • 1. The role of sexual behavior and human papillomavirus persistence in predicting repeated infections with new human papillomavirus types.
    Moscicki AB; Ma Y; Jonte J; Miller-Benningfield S; Hanson E; Jay J; Godwin de Medina C; Farhat S; Clayton L; Shiboski S
    Cancer Epidemiol Biomarkers Prev; 2010 Aug; 19(8):2055-65. PubMed ID: 20696663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type-specific human papillomavirus infections among young heterosexual male and female STI clinic attendees.
    Vriend HJ; Boot HJ; van der Sande MA; ;
    Sex Transm Dis; 2012 Jan; 39(1):72-8. PubMed ID: 22183851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Episodic detection of human papillomavirus within a longitudinal cohort of young women.
    Shew ML; Ermel AC; Tong Y; Tu W; Qadadri B; Brown DR
    J Med Virol; 2015 Dec; 87(12):2122-9. PubMed ID: 26112742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incident Detection of High-Risk Human Papillomavirus Infections in a Cohort of High-Risk Women Aged 25-65 Years.
    Winer RL; Hughes JP; Feng Q; Stern JE; Xi LF; Koutsky LA
    J Infect Dis; 2016 Sep; 214(5):665-75. PubMed ID: 27009602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural history of anal human papillomavirus infection in heterosexual women and risks associated with persistence.
    Moscicki AB; Ma Y; Farhat S; Jay J; Hanson E; Benningfield S; Jonte J; Godwin-Medina C; Wilson R; Shiboski S
    Clin Infect Dis; 2014 Mar; 58(6):804-11. PubMed ID: 24368624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency and risk factors for prevalent, incident, and persistent genital carcinogenic human papillomavirus infection in sexually active women: community based cohort study.
    Oakeshott P; Aghaizu A; Reid F; Howell-Jones R; Hay PE; Sadiq ST; Lacey CJ; Beddows S; Soldan K
    BMJ; 2012 Jun; 344():e4168. PubMed ID: 22730542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of human papillomavirus among STD clinic attenders in Jamaica: association of younger age and increased sexual activity.
    Figueroa JP; Ward E; Luthi TE; Vermund SH; Brathwaite AR; Burk RD
    Sex Transm Dis; 1995; 22(2):114-8. PubMed ID: 7624812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of risk factors for persistent infection of asymptomatic women with high-risk human papilloma virus.
    Shi N; Lu Q; Zhang J; Li L; Zhang J; Zhang F; Dong Y; Zhang X; Zhang Z; Gao W
    Hum Vaccin Immunother; 2017 Jun; 13(6):1-7. PubMed ID: 28409676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus vaccine-related risk perceptions and subsequent sexual behaviors and sexually transmitted infections among vaccinated adolescent women.
    Mullins TL; Zimet GD; Rosenthal SL; Morrow C; Ding L; Huang B; Kahn JA
    Vaccine; 2016 Jul; 34(34):4040-5. PubMed ID: 27291086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectrum of genital human papillomavirus infection in a female adolescent population.
    Jamison JH; Kaplan DW; Hamman R; Eagar R; Beach R; Douglas JM
    Sex Transm Dis; 1995; 22(4):236-43. PubMed ID: 7482107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral load and short-term natural history of type-specific oncogenic human papillomavirus infections in a high-risk cohort of midadult women.
    Winer RL; Xi LF; Shen Z; Stern JE; Newman L; Feng Q; Hughes JP; Koutsky LA
    Int J Cancer; 2014 Apr; 134(8):1889-98. PubMed ID: 24136492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of Acquisition and Clearance of Human Papillomavirus Infection in Previously Unexposed Young Women.
    El-Zein M; Ramanakumar AV; Naud P; Roteli-Martins CM; de Carvalho NS; Colares de Borba P; Teixeira JC; Moscicki AB; Harper DM; Tyring SK; Ramjattan B; Dubin G; Franco EL;
    Sex Transm Dis; 2019 Oct; 46(10):663-669. PubMed ID: 31464859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of genital human papillomavirus DNA in a sample of senior school-aged women in the Australian Capital Territory.
    O'Keefe EJ; Gardner A; Currie MJ; Garland S; Tabrizi S; Bowden FJ
    Sex Health; 2006 May; 3(2):91-4. PubMed ID: 16800394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of, and behavioural risk factors for, sexually transmitted human papillomavirus infection in men and women in Britain.
    Johnson AM; Mercer CH; Beddows S; de Silva N; Desai S; Howell-Jones R; Carder C; Sonnenberg P; Fenton KA; Lowndes C; Soldan K
    Sex Transm Infect; 2012 Apr; 88(3):212-7. PubMed ID: 22261135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrence of Genital Infections With 9 Human Papillomavirus (HPV) Vaccine Types (6, 11, 16, 18, 31, 33, 45, 52, and 58) Among Men in the HPV Infection in Men (HIM) Study.
    Pamnani SJ; Sudenga SL; Rollison DE; Ingles DJ; Abrahamsen M; Villa LL; Lazcano-Ponce E; Huang Y; Borenstein A; Giuliano AR
    J Infect Dis; 2018 Sep; 218(8):1219-1227. PubMed ID: 29800222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of sexual abuse with incident high-risk human papillomavirus infection among young African-American women.
    Wingood GM; Seth P; DiClemente RJ; Robinson LS
    Sex Transm Dis; 2009 Dec; 36(12):784-6. PubMed ID: 19704392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low prevalence of HPV in male sexual partners of HR-HPV infected females and low concordance of viral types in couples in Eastern Guangdong.
    Huang Y; Lin M; Luo ZY; Li WY; Zhan XF; Yang LY
    Asian Pac J Cancer Prev; 2013; 14(3):1755-60. PubMed ID: 23679269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender differences in sexual biomarkers and behaviors associated with human papillomavirus-16, -18, and -33 seroprevalence.
    Kreimer AR; Alberg AJ; Viscidi R; Gillison ML
    Sex Transm Dis; 2004 Apr; 31(4):247-56. PubMed ID: 15028941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and duration of type-specific human papillomavirus infection in high-risk HPV-naïve women: results from the control arm of a phase II HPV-16/18 vaccine trial.
    Ramanakumar AV; Naud P; Roteli-Martins CM; de Carvalho NS; de Borba PC; Teixeira JC; Blatter M; Moscicki AB; Harper DM; Romanowski B; Tyring SK; Ramjattan B; Schuind A; Dubin G; Franco EL;
    BMJ Open; 2016 Aug; 6(8):e011371. PubMed ID: 27566633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective study of absolute risk and determinants of human papillomavirus incidence among young women in Costa Rica.
    Clarke M; Schiffman M; Wacholder S; Rodriguez AC; Hildesheim A; Quint W;
    BMC Infect Dis; 2013 Jul; 13():308. PubMed ID: 23834901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.